Publication | Closed Access

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

Rheumatoid DisorderRheumatologyAutoimmune DiseaseMedicineRheumatic DiseasesOsteoarthritisClinical DermatologyInflammatory Rheumatic DiseaseActive Psoriatic ArthritisDermatologyPsoriatic ArthritisPlacebo-controlled Psummit 1Rheumatoid ArthritisPhase 3